Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Dynavax Technologies

Dynavax Technologies reported $221.58M in Loan Capital for its fiscal quarter ending in December of 2022.

Loan Capital Change
Agenus AGEN:US USD 12.63M 43K
Amgen AMGN:US USD 60.76B 23.41B
AstraZeneca AZN:LN USD 27.65B 3.96B
Biogen BIIB:US USD 6.28B 1.7M
BioMarin Pharmaceutical BMRN:US USD 1.08B 803K
Glaxosmithkline GSK:US GBP 16.64B 391M
Novartis NOVN:VX USD 21.99B 203M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX CHF 21.39B 978M
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
TG Therapeutics TGTX:US USD 96.5M 25.37M
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M